News-Medical.Net Gene Therapy News
-
Study: R-spondin growth factor reduces intestinal tumors in early phase of colorectal cancer
Sep 24, 2020 | 07:12 amColorectal cancer constitute the third most common cancer in the Western world. Their incidence constantly increases as the population ages, and despite recent advances in colorectal cancer therapy, the cancer metastasizes in every third of colorectal cancer patients, and a significant part of these patients eventually die from the disease
Read more... -
Study finds spectrum of genes responsible for inherited hearing loss in Israeli Jewish families
Sep 24, 2020 | 02:31 amUntil now, seven genes were known to be involved in hearing loss in Israel's Jewish population. A new study led by Zippora Brownstein, PhD, and Prof. Karen Avraham from the Sackler Faculty of Medicine at Tel Aviv University has found that 32 genes are responsible for inherited hearing loss in Israeli Jewish families.
Read more... -
OXGENE launches a scalable, plasmid-free manufacturing system for AAV
Sep 23, 2020 | 09:45 amOXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV.
Read more... -
Researchers generate accurate replications of human retinas in a dish
Sep 21, 2020 | 15:50 pmScientists have generated accurate replications of human retinas in culture that can be used to pinpoint the specific types of cells affected by genetic eye diseases.
Read more... -
Providing personalized care for bleeding disorders
Sep 21, 2020 | 10:23 amAn interview with Dr. Carmen Escuriola-Ettingshausen MD, Mörfelden-Walldorf, Germany on providing personalized care for bleeding disorders.
Read more... -
Gene therapy used to overcome the cardiac effects of Freidreich’s ataxia
Sep 20, 2020 | 03:19 amGene therapy was successfully used to overcome the cardiac effects of Freidreich’s ataxia (FA) in a mouse model of the disease, as reported in the peer-reviewed journal Human Gene Therapy. Click here to read the full-text article free online through October 18, 2020.
Read more... -
S-pseudotyped VLPs offer promising COVID-19 vaccine platform
Sep 18, 2020 | 08:18 amA new study published on the preprint server bioRxiv* in September 2020 reports on a Moloney murine leukemia virus (MLV) platform that produces VLPs expressing the important spike antigen of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Read more... -
Researchers compare developed carriers for delivery of genome editing tools with existing analogs
Sep 17, 2020 | 02:41 amResearchers from Peter the Great St.Petersburg Polytechnic University in collaboration with colleagues from the Pavlov University, ITMO University, and the University of Hamburg compared their developed carriers for delivery of genome editing (GE) tools with other available analogs.
Read more... -
UC Davis uses microneedles to deliver gene therapy for retinal diseases
Sep 17, 2020 | 01:59 amA novel approach to delivering gene therapy for retinal diseases eliminates the need for complex eye surgery and treats more damaged cells than existing methods, a team of UC Davis physicians and veterinary eye specialists has found.
Read more... -
RCas9 gene therapy clears toxic RNA buildup in mouse model of myotonic dystrophy
Sep 15, 2020 | 03:30 amMyotonic dystrophy type I is the most common type of adult-onset muscular dystrophy. People with the condition inherit repeated DNA segments that lead to the toxic buildup of repetitive RNA, the messenger that carries a gene's recipe to the cell's protein-making machinery.
Read more...